Finally, we concluded that c-Myc inhibition is capable of promoting T cell infiltration and activation in osteosarcoma in multiple ways, thus delivering a one-two punch for modulating the tumor immune microenvironment (Fig. 6D). The gene discussed is MYC; the disease is osteosarcoma.